---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-250187"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2022-09-23T23:59:59+00:00"
generated_at: "2026-06-23T07:52:31.052089+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pediatrix GC Dominic Andreano to step down; Mary Ann Moore appointed successor

## Summary
- Andreano to depart as EVP, General Counsel and Secretary effective Oct. 14, 2022.
- Termination is without cause; he will receive benefits after signing release.
- He intends to enter into a consulting agreement to advise the company post-transition.
- Mary Ann Moore, EVP, Chief Enterprise Risk & Legal Operations, will succeed as GC.

## SEC filing metadata
- accession: 0001193125-22-250187
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2022-09-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312522250187/0001193125-22-250187-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312522250187/d319654d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-250187
- JSON: https://secwatch.observer/filing/0001193125-22-250187.json
- Plain text: https://secwatch.observer/filing/0001193125-22-250187.txt

## Key facts
- Executive change
  Mary Ann Moore was appointed as Executive Vice President, General Counsel and Secretary at Pediatrix Medical Group, Inc..
  - Action: appointed
  - Role: Executive Vice President, General Counsel and Secretary
  source text: Ms. Mary Ann Moore, the Company’s Executive Vice President, Chief Enterprise Risk and Legal Operations Officer, will be appointed the Company’s Executive Vice President, General Counsel and Secretary upon Mr. Andreano’s transition from his current role.
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000119312522250187/0001193125-22-250187-index.htm
- Executive change
  Dominic J. Andreano changed role as Executive Vice President, General Counsel and Secretary at Pediatrix Medical Group, Inc..
  - Action: transition
  - Role: Executive Vice President, General Counsel and Secretary
  source text: On September 19, 2022, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), announced that Dominic J. Andreano, the Company’s Executive Vice President, General Counsel and Secretary, would transition from such position, effective on or about October 14, 2022 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/893949/000119312522250187/0001193125-22-250187-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.